Skip to Content

Elekta AB Class B

EKTA B: XSTO (SWE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
SEK 656.00RhgdFtccrqvvz

Elekta's Order Growth Still Choppy, but Long-Term Outlook Remains Attractive

Business Strategy and Outlook

Demand for radiotherapy should stay healthy over the next decade. Elekta stands to benefit, but its success depends on the continuing adoption of Unity as well as its ability to withstand competition from Siemens Healthineers.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of EKTA B so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center